Brand dynamics
Group Real-Time Dynamics And Cutting-Edge Information In The Field Of One Health
Applause! Lizhu has won the MSCI ESG Global AAA rating for consecutive years.
Time Posted：2024-08-02 12:40
Recently, MSCI (Morgan Stanley Capital International), a leading international index company, announced the latest annual ESG (Environmental, Social and Governance) rating results for Lizhu. In 2024, Lizhu's MSCI ESG rating has retained the highest global rating of AAA.
Time Posted：2024-07-30 18:05
Driven by its dual-wheel strategy of "innovative drugs + high-end complex preparations", the well-known pharmaceutical company Health Yuan is continuing to lead in the inhalation preparation field. Moreover, since its listing in 2001, Health Yuan has maintained a stable dividend policy, having distributed cash dividends to shareholders 20 times, with a cumulative dividend amount exceeding 3.6 billion yuan.
Time Posted：2024-07-30 14:55
As an active promoter and practitioner of chronic disease public welfare undertakings, Health Yuan continues to promote the "Chronic Disease Public Welfare Supporting Rural Revitalization" action to various needy areas across the country. In May, Health Yuan & Lizhu Group, in collaboration with the Chengdu Xindu Community Development Foundation, Pengzhou Civil Affairs Bureau, Pengzhou's counterpart support team for Heishui County, and Heishui County Health and Health Bureau, implemented the chronic disease public welfare action in Heishui County.
Time Posted：2024-07-29 14:35
Recently, Joincare Pharmaceutical Group Industry Co., Ltd. stood out from over 1700 Chinese companies across 60 industries, based on its outstanding performance in Environmental, Social, and Governance (ESG) criteria. It was successfully included in S&P Global's Sustainability Yearbook (China Edition) 2024 for the first time, becoming one of the five pharmaceutical companies selected. This highlights the company's achievements and influence in the field of sustainable development.
Time Posted：2024-07-27 16:00
HealthGen, a veteran biopharmaceutical company with over 20 years of market experience, has accelerated its expansion from health products to pharmaceuticals, establishing multiple R&D platforms for innovative drugs and high-barrier complex formulations.
Time Posted：2024-07-23 10:45
Guided by the national "Healthy China 2030" strategy, Health Yuan Group actively responded to the national call and is committed to improving the level of primary medical services. Recently, a donation ceremony for chronic disease prevention and public welfare to support rural revitalization, jointly organized by Health Yuan & Lizhu Pharmaceutical Group, was held in the Gaize County Government Square. Zhang Chengwei, Deputy County Head; Cidan Wangjiu, Director of the County Health and Health Commission; Han Fengyuan, Organization Department of Bomê County Committee (Ali Regional Committee Organization Department In-service Training); relevant leaders from the County Health and Health Commission, People's Hospital, and Red Cross Society; presidents of health centers in various townships; and volunteers from Health Yuan and Lizhu Group attended the event.
Time Posted：2024-07-18 16:35
Recently, Lizhu Pharmaceutical Factory of Lizhu Group Co., Ltd. (hereinafter referred to as "Lizhu Pharmaceutical"), a wholly-owned subsidiary of Lizhu Pharmaceutical Group Co., Ltd., and Neurosyn Pharma (Shanghai) Co., Ltd. (hereinafter referred to as "Neurosyn Pharma"), an international biotechnology company focusing on the development of innovative therapies for neurological and psychiatric diseases, reached an exclusive license agreement for Greater China for NS-041, a small molecule drug candidate owned by Neurosyn Pharma globally. Both parties will closely cooperate on the basis of this agreement to accelerate the listing process of NS-041.
Time Posted：2024-07-17 16:00
On July 16, S&P Global released the "2024 Sustainability Yearbook (China Edition)", featuring 129 leading industry companies. Joincare Pharmaceutical Group Industry Co., Ltd. stood out from over 1700 assessed Chinese companies across 60 industries due to its outstanding performance in Environmental, Social, and Governance (ESG) criteria. It was successfully included in the "2024 Sustainability Yearbook (China Edition)" for the first time, becoming one of the five pharmaceutical companies selected, demonstrating the company's achievements and influence in sustainable development.
Quick Navigation
+86 755-33268688 | Service Hotline
Official WeChat Official Account
Copyright © 2025 Joincare Pharmaceutical Group Industry Co., Ltd. ALL Rights Reserve.